The potential reassessment of cannabinoids, particularly at the federal level, is generating considerable buzz within the industry. A shift away from Schedule I status, often considered as outdated and hindering https://bushrazeyn778805.wikicarrier.com/1054500/pot_rescheduling_a_development_catalyst